Improving the large scale purification of the HIV microbicide, griffithsin

BMC Biotechnology

Volumn 15, Issue 1, 2015, Pages

  Fuqua, Joshua L ^a,b   Wanga, Valentine ^c   Palmer, Kenneth E ^a,b  

^a Owensboro Cancer Research Program   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Bentonite; Griffithsin; HIV; Microbicide; N. benthamiana; Protein purification; Tobacco mosaic virus

Indexed keywords

BENTONITE; CHLORINE COMPOUNDS; CHROMATOGRAPHY; COST EFFECTIVENESS; COSTS; DISEASES; FILTRATION; INDUSTRIAL PLANTS; MAGNESIUM COMPOUNDS; PLANTS (BOTANY); RECOMBINANT PROTEINS; RECOVERY; VIRUSES;

GRIFFITHSIN; MICROBICIDE; N. BENTHAMIANA; PROTEIN PURIFICATION; TOBACCO MOSAIC VIRUS;

PURIFICATION;

ENDOTOXIN; GRIFFITHSIN; MAGNESIUM CHLORIDE; MICROBICIDE; PLANT EXTRACT; UNCLASSIFIED DRUG; VIRAL PROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BENTONITE; GRIFFITHSIN PROTEIN, GRIFFITHSIA; PLANT LECTIN; RECOMBINANT PROTEIN;

ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CROP PRODUCTION; DRUG ISOLATION; NICOTIANA BENTHAMIANA; NONHUMAN; PH MEASUREMENT; PLANT LEAF; PLANT YIELD; PROTEIN EXPRESSION; PROTEIN PURIFICATION; TEMPERATURE MEASUREMENT; BIOTECHNOLOGY; CHEMISTRY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; TOBACCO;

ANTI-HIV AGENTS; BENTONITE; BIOTECHNOLOGY; MAGNESIUM CHLORIDE; PLANT LECTINS; RECOMBINANT PROTEINS; TOBACCO;

EID: 84928752690     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/s12896-015-0120-5     Document Type: Article

References (18)

1. Mori T, O'Keefe BR, Sowder 2nd RC, Bringans S, Gardella R, Berg S, et al. Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp. J Biol Chem. 2005;280(10):9345-53
2. Nixon B, Stefanidou M, Mesquita PM, Fakioglu E, Segarra T, Rohan L, et al. Griffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell Spread. J Virol. 2013;87(11):6257-69
3. Emau P, Tian B, O'Keefe BR, Mori T, McMahon JB, Palmer KE, et al. Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide. J Med Primatol. 2007;36(4-5):244-53
4. O'Keefe BR, Vojdani F, Buffa V, Shattock RJ, Montefiori DC, Bakke J, et al. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proc Natl Acad Sci U S A. 2009;106(15):6099-104
5. Giomarelli B, Schumacher KM, Taylor TE, Sowder 2nd RC, Hartley JL, McMahon JB, et al. Recombinant production of anti-HIV protein, griffithsin, by auto-induction in a fermentor culture. Protein Expr Purif. 2006;47(1):194-202
6. Kouokam JC, Huskens D, Schols D, Johannemann A, Riedell SK, Walter W, et al. Investigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate. PLoS One. 2011;6(8):e22635
7. Moulaei T, Shenoy SR, Giomarelli B, Thomas C, McMahon JB, Dauter Z, et al. Monomerization of viral entry inhibitor griffithsin elucidates the relationship between multivalent binding to carbohydrates and anti-HIV activity. Structure. 2010;18(9):1104-15
8. Ziolkowska NE, Shenoy SR, O'Keefe BR, McMahon JB, Palmer KE, Dwek RA, et al. Crystallographic, thermodynamic, and molecular modeling studies of the mode of binding of oligosaccharides to the potent antiviral protein griffithsin. Proteins. 2007;67(3):661-70
9. Brakke MK, Van Pelt N. Influence of bentonite, magnesium, and polyamines on degradation and aggregation of tobacco mosaic virus. Virology. 1969;39(3):516-33
10. O'Keefe BR, Giomarelli B, Barnard DL, Shenoy SR, Chan PK, McMahon JB, et al. Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J Virol. 2010;84(5):2511-21
11. Takebe Y, Saucedo CJ, Lund G, Uenishi R, Hase S, Tsuchiura T, et al. Antiviral Lectins from Red and Blue-Green Algae Show Potent In Vitro and In Vivo Activity against Hepatitis C Virus. PLoS One. 2013;8(5):e64449
12. Ishag HZ, Li C, Huang L, Sun MX, Wang F, Ni B, et al. Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo. Arch Virol. 2013;158(2):349-58
13. Hoorelbeke B, Xue J, Liwang PJ, Balzarini J. Role of the Carbohydrate-Binding Sites of Griffithsin in the Prevention of DC-SIGN-Mediated Capture and Transmission of HIV-1. PLoS One. 2013;8(5):e64132
14. Meuleman P, Albecka A, Belouzard S, Vercauteren K, Verhoye L, Wychowski C, et al. Griffithsin has antiviral activity against hepatitis C virus. Antimicrob Agents Chemother. 2011;55(11):5159-67
15. Xue J, Gao Y, Hoorelbeke B, Kagiampakis I, Zhao B, Demeler B, et al. The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin. Mol Pharm. 2012;9(9):2613-25
16. Barton C, Kouokam JC, Lasnik AB, Foreman O, Cambon A, Brock G, et al. Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models. Antimicrob Agents Chemother. 2014;58(1):120-7
17. Sherwood JL, Fulton RW. The specific involvement of coat protein in tobacco mosaic virus cross protection. Virology. 1982;119(1):150-8
18. Powell CA. The effect of cations on the alkaline dissociation of tobacco mosaic virus. Virology. 1975;64(1):75-85